|
Site of involvement
|
RT group
|
CCRT group
|
|---|
|
Base of tongue
|
21
|
33
|
|
Posterior pharyngeal wall
|
2
|
1
|
|
Soft palate
|
2
|
1
|
|
Tonsil
|
25
|
55
|
|
T-stage
|
RT group
|
CCRT group
|
|
1
|
8
|
16
|
|
2
|
20
|
30
|
|
3
|
16
|
22
|
|
4
|
6
|
22
|
|
N-stage**
|
RT group
|
CCRT group
|
|
0
|
17
|
9
|
|
1
|
16
|
20
|
|
2
|
14
|
48
|
|
3
|
3
|
13
|
|
Disease stage**
|
RT group
|
CCRT group
|
|
II
|
5
|
2
|
|
III
|
24
|
17
|
|
IVa
|
4
|
10
|
|
IVA
|
14
|
48
|
|
IVB
|
3
|
13
|
- **Significant to 0.001.
- Comparison of site of involvement, T-stage, N-stage, and disease stage of patients who underwent RT (n = 50) as first-line treatment as opposed to CCRT (n = 88); **Significant to 0.01.
